Content area
Full text
NEC Corporation has established a new company that promotes the development and application of therapeutic cancer peptide vaccines using advanced Artificial Intelligence (AI) technology.
The new company, CYTLIMIC Inc. (CYTLIMIC), will use NEC the WISE AI technologies combined with machine learning and experimentation to produce a unique "immune function prediction technology" that is able to efficiently discover peptides that are potential vaccines in a short period of time and at a low cost.
NEC has...